Furthermore, improved targeting of proteins implicated in TNBC cancer such as folate receptor, Urokinase Plasminogen Activator Receptor, Epidermal Growth Factor Receptor, Insulin Growth Factor 1 Receptor, Wnt Pathway, Mucin 1 (MUC1), Folate Receptor and C-X-C chemokine receptor 4 (CXCR4) [45]. The gene discussed is MUC1; the disease is cancer.